Distinct time courses of microglial and astrocytic hyperactivation and the glial contribution to pain hypersensitivity in a facial cancer model

详细信息	查看全文 | 推荐本文 |

• 作者：Teppei Sago^a ; ^b ; Kentaro Ono^a ; ^{ono@kyu-dent.ac.jp} ; Nozomu Harano^b ; Kazumi Furuta-Hidaka^b ; Suzuro Hitomi^a ; Masahito Nunomaki^b ; Mitsuhiro Yoshida^b ; Shunji Shiiba^b ; Osamu Nakanishi^b ; Kou Matsuo^a ; Kiyotoshi Inenaga^a
• 关键词：Facial cancer ; Cancer pain ; Medullary dorsal horn ; Astrocyte ; Microglia ; Propentofylline
• 刊名：Brain Research
• 出版年：2012
• 期刊代码：8_00068993
• 类别：neu
• 出版时间：31 May, 2012
• 卷：1457
• 期：Complete
• 页码：70-80
• 文件大小：1135 K

摘要

Although recent evidence suggests that central glial hyperactivation is involved in cancer-induced persistent pain, the time course of this hyperactivation and the glial contribution to pain hypersensitivity remain unclear. The present study investigated the time-dependent spatial changes of microglial and astrocytic hyperactivation in the trigeminocervical complex, which consists of the medullary (MDH) and upper cervical (UCDH) dorsal horns, and pain-related behaviors in a rat facial cancer model in which Walker 256B-cells are inoculated into the vibrissal pad. In this model, the tumors grew within the vibrissal pad, from which sensory nerve fibers project into the MDH, but did not expand into the infraorbital region, from which fibers project into the UCDH. Nevertheless, mechanical allodynia and thermal hyperalgesia were observed not only in the vibrissal pad but also in the infraorbital region. Western blotting and immunofluorescence studies indicated that microglia were widely activated in the trigeminocervical complex on day 4 and gradually inactivated by day 11. In contrast, astrocytes were only activated in the MDH on day 4; the hyperactivation later expanded into the UCDH. Daily administration of the glial hyperactivation inhibitor propentofylline beginning on day 4 suppressed the glial hyperactivation on later days. Propentofylline treatment largely prevented allodynia/hyperalgesia in the infraorbital region beginning on day 5, although established allodynia/hyperalgesia in the vibrissal pad was less sensitive to the treatment. These results suggest that central glial hyperactivation, transient microglial hyperactivation and persistent astrocytic hyperactivation, contributes to the development of pain hypersensitivity but not to the maintenance of pain in this model.